ZURICH, Aug. 15, 2025 (GLOBE NEWSWIRE) -- EAACI has launched its Antibiotic Allergy Awareness Campaign during its 2025 Congress in Glasgow. The initiative begins a global effort to address mislabelling and its link to antimicrobial resistance (AMR).

A Global Call to Action

Antibiotic allergy mislabelling affects millions worldwide. Inaccurate labels lead to avoidance of first-line treatments and overuse of second-line antibiotics, fuelling AMR. EAACI calls on all stakeholders to promote accurate diagnosis and responsible antibiotic use.

“We are launching a movement — not a moment,” said Maria Torres, EAACI President. “Too many lives are impacted by unverified allergy labels that limit treatment options and worsen health outcomes. This campaign builds momentum to correct labels, improve safety, and preserve antibiotics for future generations. Correcting labels means saving lives — now and in the future.”

The Campaign's Objectives:

Raise awareness about the dangers of incorrect antibiotic allergy labels
Empower patients and healthcare professionals with tools and training
Promote evidence-based allergy evaluation protocols
Encourage rational antibiotic prescribing to protect long-term efficacy

Breaking Down the Barriers

Many patients carry outdated, unverified, or self-reported allergy labels, reducing treatment options and increasing risk. The campaign tackles these issues through education, training, and advocacy.

Resources to Drive Change

A central feature of the campaign is a short educational video explaining antibiotic allergy and why correct labels matter. The Promotional Kit 2025 offers tools to amplify the campaign across all platforms.

Join the Movement

Launched under the slogan “Correct Labels, Better Lives,” the campaign invites professionals, educators, institutions, and individuals to join the global awareness effort. Together, we can protect the effectiveness of antibiotics.

Explore the campaign and download resources: https://eaaci.org/eaaci-antibiotic-allergy-awareness-campaign/

About EAACI

The European Academy of Allergy and Clinical Immunology (EAACI) is Europe’s largest professional association in the field, committed to advancing research and care for those affected by allergic diseases.

Learn more: https://eaaci.org

Contact: communications@eaaci.org | +41 44 205 55 33

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/f2d7cd4b-652b-4207-9c07-315528446450

This item of content is a press release from a third party provider who make no warranties or representations in connection with this content and therefore PA can make no warranties in respect of its use.

Images

Tags

More Like This

EAACI Congress Kicks Off in Valencia, Spain

EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology

EAACI Congress 2025 - Breaking Boundaries in Allergy, Asthma, and Clinical Immunology: Integrating Planetary Health for a Sustainable Future

EAACI Calls for a "Vision Zero" Future Free from Allergy and Asthma Burden

Professor Mohamed Shamji Assumes Presidency of EAACI as Congress 2026 Concludes in Istanbul

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

EAACI Congress 2024: Innovation and Advances in Allergy Treatment

EAACI Hong Kong Allergy School 2025: A Landmark in Global Allergy Education